Medication Trial for Social and Communication Deficits Posted April 19, 2017 | Leave a comment We are looking for children and adolescents, ages 5-17, for a study involving a new medication for Autism. The aViation study will test a potential new treatment for ‘high-functioning’ autism spectrum disorder (ASD). The investigational study drug blocks a hormone receptor in the brain that is linked to the control of socialization, stress, anxiety and aggression. Participation lasts for up to 39 weeks. For 24 of those weeks, they will take daily doses of either the investigational study drug or a placebo (a look-alike) that contains no medicine. Both the investigational study drug and the placebo are small tablets that can be swallowed whole or dissolved in liquid. Your time will be compensated. This study is sponsored by Roche Pharmaceuticals. If interested, please contact Matthew Maloney at 615-343-2018 or email@example.com” Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)Click to share on Google+ (Opens in new window) Related Write a Comment Cancel reply Your email address will not be published. Required fields are marked * Submit Notify me of follow-up comments by email. Notify me of new posts by email.